Medtronic reported its first quarter fiscal 2025 financial results, showcasing a strong performance that exceeded market expectations. The company achieved a revenue of $7.92 billion, marking a 2.8% increase year-over-year, with the cardiovascular segment contributing $3.01 billion. Medtronic's earnings per share stood at $1.23, surpassing forecasts. The company slightly raised the lower end of its annual profit forecast, driven by sustained demand for its medical devices and new product launches. Medtronic's CEO highlighted the healthy underlying markets and the company's focus on operating rigor and product innovation, which are fueling diversified growth across key health tech markets. Following the earnings announcement, Medtronic's stock saw a modest increase, with shares up 1.6%.